In a report released on March 14, Kerry Holford from Berenberg Bank maintained a Hold rating on Novartis AG (NOVN – Research Report), with a ...

Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG (NOVN – Research Report) on March 13 and set a price target of ...

We recently compiled a list of the 11 Best Undervalued Stocks to Invest in Now. In this article, we are going to take a look ...

Novartis AG (NYSE:NVS – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors acquired 54,767 call options on the stock. This represents an increase of 2,389% ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other undervalued stocks. On March 5th, BBC reported that the US stock market had fallen after the ...

(Bloomberg) -- Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 billion). The Sandoz Family Foundation, through the vehicle ...

Multiple Sclerosis Therapeutics Size Multiple Sclerosis Therapeutics Market is estimated to be valued at USD 31.39 Bn in 2025 and is expect ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against other best global stocks to buy according to hedge funds. The United States has long been a magnet for ...

Kyorin Pharmaceutical Co. Ltd. has out-licensed its preclinical candidate, KRP-M223, and its back-up compounds to Novartis Pharma AG in a deal worth up to $777.5 million. Under the terms, Novartis ...